GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » Total Assets

Bioray Biotech Co (ROCO:7561) Total Assets : NT$550.1 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co Total Assets?

Bioray Biotech Co's Total Assets for the quarter that ended in Jun. 2024 was NT$550.1 Mil.

During the past 12 months, Bioray Biotech Co's average Total Assets Growth Rate was -11.70% per year. During the past 3 years, the average Total Assets Growth Rate was 10.50% per year. During the past 5 years, the average Total Assets Growth Rate was 16.50% per year.

During the past 7 years, Bioray Biotech Co's highest 3-Year average Total Assets Growth Rate was 44.80%. The lowest was 10.50%. And the median was 17.80%.

Total Assets is connected with ROA %. Bioray Biotech Co's annualized ROA % for the quarter that ended in Jun. 2024 was -3.76%. Total Assets is also linked to Revenue through Asset Turnover. Bioray Biotech Co's Asset Turnover for the quarter that ended in Jun. 2024 was 0.16.

Bioray Biotech Co Total Assets Historical Data

The historical data trend for Bioray Biotech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co Total Assets Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 499.74 475.80 466.18 598.63 542.65

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 456.11 598.63 565.07 542.65 550.06

Bioray Biotech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Bioray Biotech Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=433.896+108.752
=542.6

Bioray Biotech Co's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=416.965+133.097
=550.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioray Biotech Co  (ROCO:7561) Total Assets Explanation

Total Assets is connected with ROA %.

Bioray Biotech Co's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-20.53/( (542.648+550.062)/ 2 )
=-20.53/546.355
=-3.76 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Bioray Biotech Co's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=85.795/( (542.648+550.062)/ 2 )
=85.795/546.355
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Bioray Biotech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioray Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » Total Assets
Comparable Companies
ROCO:6483 ROCO:6935 ROCO:5398 ROCO:6621 ROCO:6539 ROCO:4117 ROCO:6677 ROCO:6496 ROCO:4172 ROCO:6817 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Website
https://www.bio-ray.com.tw
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co Headlines

No Headlines